We offer particular expertise in the area of biotechnology, with our team of biotech patent attorneys having specific backgrounds and clients in this sector, providing you with a comprehensive service.
Intellectual property is an essential asset to biotechnology organisations. Only by achieving secure protection can the huge investment necessary to bring a biotech product to market be safeguarded and an adequate return on that investment realised. In biotechnology, the range of developments that can be protected by biotech patents is extensive, from newly recognised genes and stem cell technology to microbiology and fermentation. As experienced biotech patent attorneys, we help clients build effective biotechnology patent portfolios covering the whole spectrum of developments in this field, for example:
AdamsonJones is pleased to announce that David Gwilliam, Eilidh Pugh and Jenny Vaughan have all been promoted to the position of Partner.